Skip to main content
VCbacked
Log inGet Started

Ajax Therapeutics

Cambridge, United States

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

$95.0M raised
May 2024
Series C
BiotechnologyLife ScienceMedical

Top Investors

RA Capital ManagementVivo CapitalEcoR1 CapitalGoldman Sachs Asset ManagementSchrodinger

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ajax Therapeutics

How much funding has Ajax Therapeutics raised?
Ajax Therapeutics has raised $95.0M in total funding. The most recent round was Series C. The last funding was announced in May 2024.
Who are Ajax Therapeutics's investors?
Ajax Therapeutics's investors include RA Capital Management, Vivo Capital, EcoR1 Capital, Goldman Sachs Asset Management, Schrodinger.
Where is Ajax Therapeutics headquartered?
Ajax Therapeutics is headquartered in Cambridge, United States.
What does Ajax Therapeutics do?
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
What stage is Ajax Therapeutics at?
Ajax Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ajax Therapeutics — Funding & Investors." VCBacked, May 13, 2024, https://www.vcbacked.co/company/ajax-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Ajax Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ajax-therapeutics
Wikipedia (cite web)
{{cite web |title=Ajax Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ajax-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong